Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune System Modulation via Treg and Breg Induction, Th2 Cytokine Reduction, IgE Suppression, and IgG4 Increase (None)
- Target
- None
- Molecular classification
- Immune Modulation, Cytokine Regulation, Antibody Regulation
01
Overview
This immunomodulatory target involves a coordinated set of mechanisms that collectively promote immune tolerance and suppress allergic or autoimmune responses. The key features include: induction of regulatory T cells (Tregs) and regulatory B cells (Bregs), reduction in Th2 cytokine production, suppression of allergen-specific IgE antibody production, and an increase in non-inflammatory/blocking antibodies such as IgG4. These processes are central to the control of hypersensitivity reactions, allergy, autoimmunity, and maintenance of immune homeostasis.
02
Mechanism of action
Immunomodulation to promote tolerance and suppress allergic/autoimmune responses, including Treg/Breg induction, Th2 cytokine reduction, IgE suppression, and IgG4 increase.
03
Biological functions
Immune toleranceSuppression of allergic responsesSuppression of autoimmune responsesRegulation of Th2 responsesB cell regulationT cell regulation
04
Disease associations
AllergyAutoimmune diseaseAsthmaHypersensitivity
05
Safety considerations
Potential for immunosuppressionRisk of infectionDevelopment of autoimmunity
06
Interacting drugs
Omalizumab
07
Biomarkers
Th2 cytokines (IL-4, IL-5, IL-13)Allergen-specific IgEAllergen-specific IgG4FoxP3 expressionIL-10 production
Beyond the preview
Go deeper on Immune System Modulation via Treg and Breg Induction, Th2 Cytokine Reduction, IgE Suppression, and IgG4 Increase (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immune System Modulation via Treg and Breg Induction, Th2 Cytokine Reduction, IgE Suppression, and IgG4 Increase (None).